An angle I'm seeing more and more of is bios with late stage products discussing how doctors will be motivated to use because they'll be compensated per procedure. This question is coming up more, ok, great product, but will doctors get paid and be properly motivated? Saw one company recently with a non ideal delivery (intravesical-direct to the bladder) but investors lining up to go in because the drug probably works and docs are going to get paid, so surely it will do well! :)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.